.
MergerLinks Header Logo

New Deal


Announced

Completed

A consortium of investors completed the acquisition of Syneos Health for $7.1bn.

Financials

Edit Data
Transaction Value£5,627m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium24%
One Off Charge-

Tags

Edit

Acquisition

Biotechnology

Majority

biotechnology

Domestic

Friendly

health care

Private Equity

Privatisation

United States

Public

Completed

Synopsis

Edit

A consortium of investors, including Elliott, Patient Square and Veritas Capital, completed the acquisition of Syneos Health, a health care company, for $7.1bn. “The company has a strong operating foundation, differentiated, integrated solutions and a focus on being committed to customers. We believe this transaction will enable Syneos Health to continue to accelerate its growth strategy, enhance customer delivery and evolve the organization toward a tech-enabled future,” John Dineen, Syneos Health Chairman.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US